Skip to main content

Daniel Len Edmonston

Assistant Professor of Medicine
Medicine, Nephrology

In the News


Published October 10, 2025
CKD in T2D: Evaluating Concordance With Screening and Treatment Guidelines
Published July 10, 2025
Few with type 2 diabetes receive guideline-recommended CKD screening
Published August 19, 2024
Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes
Published August 12, 2024
Kidney, CV outcomes similar SGLT2 inhibition vs. GLP-1s for diabetes
Published July 2, 2024
CKD screening rate very low among patients with type 2 diabetes
Published November 3, 2020
Novel Trial Designs May Accelerate Drug Development for Kidney Disease
Published June 16, 2020
Line Between Hypertension, Kidney Complications in Patients with COVID-19 Not Well Understood
Published July 30, 2019
2019 National Young Investigators Forum Winners
Published July 1, 2019
Google Scholar
Published July 1, 2019
Daniel Len Edmonston
Published July 1, 2019
Daniel Edmonston, MD, MHS
Published July 1, 2019
Dr. Daniel Edmonston MD
Published July 1, 2019
ResearchGate
Published July 1, 2019
Daniel Edmonston
Published July 1, 2019
Doximity
Published June 19, 2018
SGLT2 Inhibitors May Benefit Patients with Kidney and Cardiovascular Disease